On 22/6, the Drug Administration of Vietnam (Ministry of Health) issued the recall after discovering the violations. Two skincare products, Queendoes Rhea Serum and Renewing Concentrate, were recalled and ordered to be destroyed due to inconsistencies between their formulas and the registered documentation.
18 other products, including Queendoes Essential Ac Healer Serum, Dr.IASO AC Booster, The Skin House Crystal Whitening Plus Serum, DR.IASO Triple-M Hydrating Cream, Queendoes Essential PDRN Serum, The Skin House Wrinkle System Cream, Dermal Hyaluron Filler3 Concentrate, and Dermal Mimic Lift Concentrate, were recalled due to labeling discrepancies with the registered product information. If the labels cannot be separated from these products, they must also be destroyed.
Local health departments have been instructed to notify businesses using these 20 products to immediately cease sales and use, and to return the products to their suppliers. The products are also being actively recalled from the market.
The Drug Administration of Vietnam has also revoked the 20 product notification numbers for these cosmetics. Additionally, the agency has temporarily suspended the review and acceptance of cosmetic product notification dossiers from Dai Cat A International Co., Ltd., for six months, effective 20/6.
Any applications for product notification numbers submitted by Dai Cat A International Co., Ltd. before 20/6 are now invalid. Once the suspension period ends, the company must resubmit applications following current regulations.
Consumers are advised to carefully check product names, batch numbers, and origins before use. Using products with unverified formulas or effects could harm skin health and potentially cause adverse reactions.
 |
Queendoes Rhea Serum as advertised on the website of Dai Cat A International Co., Ltd. Screenshot |
Queendoes Rhea Serum as advertised on the website of Dai Cat A International Co., Ltd. Screenshot
Recently, the Ministry of Health and local health authorities have uncovered numerous violations at production and distribution facilities, leading to the recall and destruction of counterfeit and substandard drugs and cosmetics. During a recent intensive inspection period, the Drug Administration of Vietnam conducted surprise inspections at 38 facilities, finding violations at 17. Inspection teams in 20 provinces and cities also inspected 865 drug and cosmetic production, import, and distribution facilities, uncovering violations at 48.
In response to these issues, the Ministry of Health is developing and implementing comprehensive solutions, including reviewing regulations to strengthen penalties and deter violations. They are also increasing the effectiveness of inspections and supervision at all management levels, developing a database of registered drugs, and connecting pharmaceutical businesses to track the origin and source of drugs. Enhanced post-market surveillance, regular and surprise inspections are also planned.
Le Nga
